Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerro-alloy Resources Limited Regulatory News (FAR)

Share Price Information for Ferro-alloy Resources Limited (FAR)

Share Price is delayed by 15 minutes
Get Live Data
5.00    0.00 (0.00%)
Bid:
4.90
Ask:
5.10
Spread: 0.20 (4.082%)
Market Cap: £29.39m
FAR Live PriceLast checked at - London Stock Exchange

Intraday Ferro-alloy Resources Limited Share Chart

Result of Placing and Subscriptions

15 Sep 2022 12:20

RNS Number : 6333Z
Ferro-Alloy Resources Limited
15 September 2022
 

NOT FOR DISTRIBUTION OR FOR PUBLICATION, RELEASE OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF THE SECURITIES LAWS OF SUCH JURISDICTIONS.

 

FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND SHALL NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY NEW ORDINARY SHARES OF FERRO-ALLOY RESOURCES LIMITED IN ANY JURISDICTION IN WHICH ANY SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 (INCLUDING AS IT FORMS PART OF THE LAWS OF ENGLAND AND WALES BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR").

 

 

 

15 September 2022

Ferro-Alloy Resources Limited

 

("Company" or the "Group")

 

Result of Placing and Subscriptions

 

Ferro-Alloy Resources Limited (LSE:FAR), the vanadium mining and processing company with operations based in Southern Kazakhstan, is pleased to announce that, following the announcement earlier today (the "Launch Announcement") regarding the launch of a proposed placing (the "Placing") and direct subscriptions (the "Subscriptions"), the Company has raised gross proceeds of £8.2 million (approximately US$9.5 million) through the issue of an aggregate of 68,424,084 new ordinary shares of no par value ("Ordinary Shares") in the capital of the Company at a price of 12.0 pence per Ordinary Share (the "Issue Price"). The Placing and Subscriptions were supported by both existing shareholders and new investors.

Earlier today the Company also announced the launch of a PrimaryBid Offer for up to £0.4 million (approximately $0.5 million) which is expected to close at 2.00 p.m. today. The Company will announce the results of the PrimaryBid Offer thereafter. In total the Placing, Subscriptions and PrimaryBid Offer (the "Fundraising") will raise gross proceeds before expenses of £8.6 million (approximately US$10.0 million) for the Company.

 

The Placing was conducted through an accelerated bookbuild process (the "Bookbuild") undertaken by Liberum Capital Limited ("Liberum") and Shore Capital Stockbrokers Limited ("Shore") acting as Joint Bookrunners (together the "Joint Bookrunners").

Together the Placing and Subscriptions comprised of a Placing of 64,007,418 new Ordinary Shares ("Placing Shares") to raise approximately £7.7 million (approximately US$8.9 million) and Subscriptions of 4,416,666 new Ordinary Shares ("Subscription Shares") to raise approximately £0.5 million (approximately US$0.6 million).

The Issue Price represents a discount of approximately 17.9 per cent. to the closing price of 14.6 pence per Ordinary Share on 14 September 2022, being the last business day prior to the Launch Announcement.

 

Admission and Total Voting Rights

Application will be made to the FCA for the Placing Shares and Subscription Shares to be admitted to the standard listing segment of the Official List and to the London Stock Exchange for the Placing Shares and the Subscription Shares to be admitted to trading on its Main Market for listed securities ("Admission"). It is anticipated that Admission will become effective, and that dealings in the Placing Shares and the Subscription Shares will commence at or around 8.00 a.m. on 23 September 2022. The Placing Shares and the Subscription Shares will rank pari passu with the existing Ordinary Shares in issue. The Placing Shares and Subscription Shares will represent approximately 15.2 per cent. of the Company's enlarged issued share capital in aggregate on Admission (assuming no other issuance of Ordinary Shares prior to Admission).

The Company will provide a further update with respect to the Total Voting Rights in issue following Admission after the completion of the Primary Bid Offer, the result of which is expected to be announced later today.

Related Party Transaction

Vision Blue Resources Limited ("VBR"), the Group's strategic investor and substantial shareholder, as defined by the Listing Rules, has participated in the Placing by subscribing for 39,243,021 Ordinary Shares at the Issue Price. VBR is also a person closely associated with the Company's Chairman, Sir Mick Davis. VBR has also committed to subscribe for additional new Ordinary Shares in the Placing if the PrimaryBid Offer is not fully subscribed such that the total amount raised by the PrimaryBid Offer together with VBR's additional allocation in the Placing will total £0.4 million (approximately US$0.5 million).

Participation by VBR in the Placing constitutes a Related Party Transaction pursuant to the Disclosure, Guidance and Transparency Rules. The Independent Directors have considered the terms of the transaction and concluded they are fair and reasonable insofar as shareholders are concerned.

Confirmation of VBR's resultant interest in the Ordinary Shares in the Company will be announced following the results of the PrimaryBid Offer later today.

The Company and VBR have now entered into the Deed of Variation which has varied the Investment Agreement as described in the Launch Announcement and the Company has executed the 2022 Convertible Loan Note Instrument and issued to VBR notes in the amount of US$4.2 million, to in effect extend the conversion date, details and the terms of which are set out in the Launch Announcement.

Director Participation in the Subscriptions

In addition to the participation by VBR, certain Directors of the Company and others have now subscribed for a total of 4,416,666 Subscription Shares in aggregate. The beneficial holdings of the Directors before and after the Fundraising are set out below:

 Director

Existing beneficial shareholding

Fundraising Shares

 Beneficial shareholding following the Fundraising

Shareholding as a percentage of the Enlarged Issued Share Capital

Nicholas Bridgen

49,738,800

3,333,333

53,072,133

11.8%

Chris Thomas

5,758,512

708,333

6,466,845

1.44%

 

 

 

Capitalised terms not defined in this Announcement have the meaning given to them in the Launch Announcement.

For more information please contact:

Enquiries:

Ferro-Alloy Resources Limited

 

Nick Bridgen (CEO)

info@ferro-alloy.com

William Callewaert (CFO)

 

 

 

Joint Broker and Joint Bookrunner

 

Shore Capital Stockbrokers Limited

 

Toby Gibbs / John More

+44 (0) 20 7408 4090

 

 

Joint Broker and Joint Bookrunner

 

Liberum Capital Limited

 

Scott Mathieson / William King

+44 (0) 20 3100 2000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROISFAFFIEESEFU
Date   Source Headline
6th May 20267:00 amRNSNon-Executive Director Share Sale
1st May 20267:00 amRNSGrant of Share Options
30th Apr 20267:00 amRNS2025 Final Results
1st Apr 20267:00 amRNSTotal Voting Rights & Admission of Shares
10th Mar 20267:00 amRNSIssue of Equity
19th Jan 20267:00 amRNSCarbon Black Substitute MOU
5th Dec 20257:00 amRNSIssue of Equity
14th Nov 20254:55 pmRNSResult of 2025 AGM
5th Nov 20257:00 amRNSIssue of Equity
4th Nov 20257:17 amRNSProject Finance Expression of Interest
13th Oct 20257:00 amRNSPositive Feasibility Study Results
9th Oct 20257:00 amRNSNotice of AGM
30th Sep 20257:00 amRNSInterim Results and feasibility study update
7th Jul 20257:00 amRNSIssue of Equity
27th Jun 20257:00 amRNSCBS Product Update and Feasibility Study Update
23rd Jun 20257:00 amRNSAppointment of Lead Financial Adviser
2nd Jun 20257:00 amRNSFramework Agreement for Phase 1 of Balasausqandiq
2nd May 20257:00 amRNSGrant of Share Options
30th Apr 20257:00 amRNS2024 Final Results
6th Mar 20257:00 amRNSIssue of Equity to Supplier
19th Dec 202412:10 pmRNSIssue of Equity to Directors & Share Subscription
17th Dec 20247:00 amRNSNon-Binding Offtake Term Sheet for Balasausqandiq
2nd Dec 20247:00 amRNSStrategic Focus on Carbon Black Substitute
29th Nov 20247:00 amRNSKazakhstan Exempt Offer Bond Programme Update
21st Nov 20247:00 amRNSCommercial Potential of Carbon Black Substitute
24th Oct 20247:00 amRNSQ3 2024 Production Results
23rd Oct 20244:52 pmRNSResult of 2024 AGM
26th Sep 20247:00 amRNSInterim Results
19th Sep 20247:00 amRNSNotice of AGM
18th Jul 20247:00 amRNSQ2 2024 Production Results
29th Apr 20247:00 amRNSFinal Results
26th Apr 20247:00 amRNSQ1 2024 Production Results
15th Feb 20241:00 pmRNSSale of 3rd Tranche of Exempt Offer Bond Programme
1st Feb 20247:00 amRNSFeasibility Study Update & Bond Programme
12th Jan 20247:00 amRNSQ4 2023 Production Results
22nd Dec 20237:00 amRNSTrading Update
30th Nov 20237:00 amRNSTotal Voting Rights
22nd Nov 20237:00 amRNSHolding(s) in Company
21st Nov 202312:17 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSIssue of Equity
1st Nov 20235:08 pmRNSResult of AGM
17th Oct 20237:00 amRNSExempt Offer Bond Programme - Second Tranche Sale
10th Oct 202312:53 pmRNSExisting Operation Q3 Production Results
6th Oct 20237:00 amRNSNotice of AGM
19th Sep 20237:00 amRNSExempt Offer Bond Programme - Second Tranche
12th Sep 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSGrant of Share Options
11th Sep 20237:00 amRNSHalf-year Report
21st Aug 20237:00 amRNSTrading Update
27th Jul 20239:00 amRNSLaunch of Bond Programme /Listing of First Tranche

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.